SRm160 inhibitors are a class of chemical compounds that target the SRm160 protein, which plays a crucial role in the regulation of pre-mRNA splicing. SRm160, along with other associated factors, is part of the spliceosome, a highly dynamic ribonucleoprotein complex responsible for the precise removal of introns from pre-mRNA transcripts. SRm160 is known to act as a coactivator in splicing regulation by interacting with other splicing factors, such as SR proteins, and influencing alternative splicing events. This regulation is essential in the production of mature mRNA, affecting gene expression and ultimately cellular functions. Inhibitors of SRm160 disrupt these protein-protein or protein-RNA interactions, leading to alterations in the splicing machinery's activity and impacting the overall efficiency and accuracy of the splicing process.
By modulating the activity of SRm160, these inhibitors provide insight into the complex mechanisms governing alternative splicing. The ability to selectively inhibit SRm160 has been of particular interest in the study of splicing dysregulation, where errors in the splicing process can lead to aberrant gene expression and diverse phenotypic outcomes at the cellular level. Research into SRm160 inhibitors also aids in elucidating the detailed structure-function relationships within the spliceosome, contributing to a broader understanding of RNA processing. Furthermore, this chemical class provides useful tools for probing the molecular intricacies of spliceosome assembly and function, offering new avenues for exploring how splicing factors are regulated in normal and pathological conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may downregulate SRm160 by inhibiting the activity of RNA polymerase II at the SRm160 gene promoter, leading to decreased transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could decrease SRm160 expression by inhibiting the activation of NF-κB, a transcription factor that may control SRm160 gene transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 could inhibit transcription of SRm160 by displacing bromodomain-containing proteins from chromatin at the SRm160 locus, reducing transcriptional initiation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might reduce SRm160 mRNA synthesis by specifically inhibiting mTORC1, which is known to control the transcription of certain spliceosome components. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may decrease SRm160 transcription by causing hypomethylation of CpG islands in the gene's promoter region, leading to transcriptional silencing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could decrease SRm160 transcription by inhibiting histone deacetylase, resulting in hyperacetylated histones and suppressed gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 might downregulate SRm160 by inhibiting PI3K, leading to reduced activation of AKT and subsequent transcription factors critical for SRm160 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 could reduce SRm160 levels by inhibiting MEK1/2, thereby decreasing ERK pathway signaling, which is necessary for transcription of some genes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 might inhibit SRm160 transcription by blocking JNK activity, which can be required for the expression of specific spliceosome-related genes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 could decrease SRm160 expression by inhibiting p38 MAPK, which may be necessary for activating transcription factors that promote SRm160 gene transcription. | ||||||